微粒体甘油三酯转移蛋白编码变异可同时减轻肝脂肪变性和降低血浆脂质
研究在Penn Medicine生物样本库(n=37,960)和UK Biobank(n=451,444)中分析MTTP错义变异与代谢、肝脏及临床表型的关联。结果显示,I128T变异(rs3816873-A,频率26%)与活检证实的肝脂肪变性减少相关(p < 0.001),并与血浆LDL胆固醇和载脂蛋白B水平降低相关(均p < 0.001)。功能研究提示I128T既非经典功能缺失也非功能获得等位基因,其 paradoxical 特征提示对MTP功能有更复杂的影响。
要点
- MTTP I128T变异与活检证实的肝脂肪变性减少相关(p < 0.001)。
- MTTP I128T变异与血浆LDL胆固醇和载脂蛋白B水平降低相关(均p < 0.001)。
- 功能研究提示I128T既非经典功能缺失也非功能获得等位基因。
核心结论
- MTTP I128T与肝脂肪变性减少以及血浆脂质和载脂蛋白B降低相关。
- 该矛盾特征不符合MTP活性的简单功能获得或缺失,提示对MTP功能有更复杂的影响。
- 进一步研究MTTP I128T将有助于理解MTP的结构功能,并可能为调节MTP活性以同时减少肝脏和循环脂质提供新途径。
研究设计与样本
- 在Penn Medicine生物样本库(PMBB;n = 37,960)和UK Biobank(UKB;n = 451,444)中分析MTTP错义变异与代谢、肝脏及临床表型的关联。
主要发现
- 在PMBB中分析24个MTTP错义变异与活检证实的肝脂肪变性的关联,发现异亮氨酸128至苏氨酸变异(I128T:rs3816873-A,频率26%)与脂肪变性减少相关(p < 0.001)。
- PMBB中影像学证实的脂肪变性受试者与对照相比,MTTP I128T携带者显著更少。
- UKB分析也显示MTTP I128T与肝脂肪变性风险降低相关。
- MTTP I128T与血浆LDL胆固醇和载脂蛋白B水平降低相关(均p < 0.001)。
- 功能研究表明MTTP I128T既非经典功能缺失也非功能获得等位基因。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Genetic inactivation and pharmacologic inhibition of the microsomal triglyceride transfer protein (MTP; gene name MTTP) inhibits hepatic secretion of VLDL, thereby reducing serum lipids and apoB at the expense of increasing hepatic steatosis. AIM: To examine the effects of missense variants in MTTP on hepatic and circulating lipids. METHODS: We analysed the association of MTTP missense variants with metabolic, hepatic and clinical phenotypes in the Penn Medicine Biobank (PMBB; n = 37,960) and the UKBiobank (UKB; n = 451,444). RESULTS: We analysed 24 missense variants in MTTP in PMBB for association with biopsy-proven hepatic steatosis and found that an isoleucine 128 to threonine variant (I128T: rs3816873-A, frequency 26%) was associated with reduced steatosis (p < 0.001). PMBB subjects with imaging-proven steatosis also revealed significantly fewer carriers of MTTP I128T compared to controls. Analysis in UKB also showed that MTTP I128T was associated with reduced risk of hepatic steatosis. Unexpectedly, MTTP I128T was found to be associated with reduced plasma levels of LDL-cholesterol and apoB (all p < 0.001). Functional studies indicated that MTTP I128T is neither a classic loss nor gain of function allele. CONCLUSIONS: MTTP I128T is associated with reduced hepatic steatosis as well as reduced plasma lipids and apoB. This paradoxical profile is not consistent with a simple gain or loss of function in MTP activity and suggests a more complex effect on MTP function. Further investigation of MTTP I128T will provide insight into the structure-function of MTP and potentially new approaches to modulate MTP activity that could both reduce hepatic and circulating lipids.
引用
- Schneider CV, Hehl L, Creasy KT, et al. A coding variant in the microsomal triglyceride transfer protein reduces both hepatic steatosis and plasma lipids. Aliment Pharmacol Ther. 2023. PMID: 37248657. doi:10.1111/apt.17566
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。